Orange Book product · Generic (ANDA)
MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL
At a glance
Oct 22, 2024
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 22, 2024
1 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
MYCOPHENOLATE MOFETIL
Strength
250MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 207022
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of MYCOPHENOLATE MOFETIL
- 2024MYHIBBINBrand (NDA)
NDA 216482 · AZURITY
- 1998CELLCEPTBrand (NDA)
NDA 050759 · ROCHE PALO
- 1997CELLCEPTBrand (NDA)
NDA 050723 · ROCHE PALO
- 1995CELLCEPTBrand (NDA)
NDA 050722 · ROCHE PALO
- 2026MYCOPHENOLATE MOFETILGeneric (ANDA)
ANDA 218566 · CONCORD BIOTECH LTD
- 2024MYCOPHENOLATE MOFETILGeneric (ANDA)
ANDA 214079 · WUXI
- 2024MYCOPHENOLATE MOFETILGeneric (ANDA)
ANDA 208119 · HETERO LABS LTD V
- 2024MYCOPHENOLATE MOFETILGeneric (ANDA)
ANDA 218227 · AUROBINDO PHARMA LTD
- 2024MYCOPHENOLATE MOFETILGeneric (ANDA)
ANDA 217937 · AUROBINDO PHARMA
- 2024MYCOPHENOLATE MOFETILGeneric (ANDA)
ANDA 217828 · AUROBINDO PHARMA LTD
- 2023MYCOPHENOLATE MOFETILGeneric (ANDA)
ANDA 213955 · RISING
- 2023MYCOPHENOLATE MOFETILGeneric (ANDA)
ANDA 212634 · STRIDES PHARMA INTL
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
